Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000281252

Medchemexpress LLC Rebamipide impurity 13 | 4876-17-9 | MFCD22194962 | 698.0% | 193.63 | C10H8ClNO | 50 MG
SDP

Catalog No. 5000281252
Encompass_Preferred

Rebamipide impurity 13 is supplied for research use as a drug intermediate and chemical impurity of rebamipide. It is provided as a stable powder with recommended cold storage and is intended for laboratory studies of impurity profiling, synthesis, and analytical method development.

  • Intended use: drug intermediate and impurity studies.
  • CAS number: 4876-17-9.
  • Molecular formula: C10H8ClNO.
  • Molecular weight: 193.63 g/mol.
  • Purity: ≥98.0%.
  • Storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).
  • For research use only; not for human or clinical use.

Catalog No. 50-002-81252 Supplier Medchemexpress LLC Supplier No. HYW25099550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Rebamipide impurity 13 is supplied for research use as a drug intermediate and chemical impurity of rebamipide. It is provided as a stable powder with recommended cold storage and is intended for laboratory studies of impurity profiling, synthesis, and analytical method development.

  • Intended use: drug intermediate and impurity studies.
  • CAS number: 4876-17-9.
  • Molecular formula: C10H8ClNO.
  • Molecular weight: 193.63 g/mol.
  • Purity: ≥98.0%.
  • Storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).
  • For research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.